Acer Therapeutics Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.67
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.68
|
-0.31
|
0.37
|
54.41%
|
|
2022-06-30
|
-0.57
|
-0.17
|
0.40
|
70.18%
|
|
2022-03-31
|
-0.41
|
-0.64
|
-0.23
|
-56.10%
|
|
2021-12-31
|
-0.01
|
-0.31
|
-0.30
|
-3000.00%
|
|
2021-09-30
|
-0.28
|
-0.23
|
0.05
|
17.86%
|
|
2021-06-30
|
-0.36
|
-0.23
|
0.13
|
36.11%
|
|
2021-03-31
|
-0.44
|
-0.11
|
0.33
|
75.00%
|
|
2020-12-31
|
-0.41
|
-0.50
|
-0.09
|
-21.95%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.12
|
|
2021-12-31
|
-0.88
|
|
2020-12-31
|
-2.06
|
|
2019-12-31
|
-2.91
|
|
2018-12-31
|
-2.45
|
|
2017-12-31
|
-3.89
|
|
2016-12-31
|
-10.15
|
|
2015-12-31
|
-8.98
|
|
2014-12-31
|
-25.28
|
|
2012-12-31
|
-128.28
|
|
2011-12-31
|
-86.02
|
|
2010-12-31
|
-110.95
|
|
2009-12-31
|
-388.82
|
|
2007-12-31
|
-725.79
|
|
2006-12-31
|
-817.24
|
|
2005-12-31
|
-4146.77
|
|
2004-12-31
|
-27079.76
|
|
2001-12-31
|
-9921.44
|
|
2000-12-31
|
-5175.19
|